Skip to content
Recall Observatory FDA recall evidence

Device product

DRI Salicylate Serum Tox Assay, Catalog number 0977. Toxicology: The DRI Salicylate Serum Tox Assay is intended for the quantitative determination of salicylate in human serum or plasma.

Z-2884-2016

July 25, 2016

Class II

Product summary

Firm
Microgenics Corporation
Event
Event 74861
Status
Terminated
Classification
Class II
Quantity
1708 kits
Official record key
device-enforcement:Z-2884-2016

Official wording

Reason: Some lots of DRI Salicylate Serum Tox Assay negative patient samples are recovering higher than the product sensitivity claim of 4.4 mg/dL.

Code information: Lot Number Expiration Date 60704602 DEC 2016; 72035410 JUL 2017; 72208738 FEB 2018; 72409454 OCT 2018.

Distribution pattern: Worldwide Distribution: US (nationwide) to states of: AZ, CA, MO, TX, and PR and countries of: Canada, Germany, Hong Kong, Italy, Malaysia, and Taiwan.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Some lots of DRI Salicylate Serum Tox Assay negative patient samples are recovering higher than the product sensitivity claim of 4.4 mg/dL.